Companies / ReviveMed
ReviveMed
United States
ReviveMed uses AI and metabolites to develop precision medicine for diseases such as cancer and obesity
ReviveMed, based in United States, has 2 investors on file, among them Good Growth Capital and HalfCourt Capital. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
3 filingsFiled by ReviveMed, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Good Growth Capital
54 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (37%), Climate & Energy (20%), AI & Machine Learning (11%).
See Good Growth Capital's full profile · Who invests alongside it
More from HalfCourt Capital
30 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (37%), Healthcare & Biotech (26%), Robotics & Hardware (19%).
See HalfCourt Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get ReviveMed and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Good Growth Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/revivemed.io/investors
# also
GET /v1/companies/revivemed.io
GET /v1/companies/revivemed.io/news